menu
    • menu

    Company profile for TScan Therapeutics

    NEW Drugs in Dev: 8
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    TScan discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors, and other serious diseases. Our proprietary, high-throughput platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of highly efficacious TCR-Ts with minimal off-target effects. Lead program TSC-100 is expected to enter clin...
    TScan discovers and develops transformative T cell therapies (TCR-T) to treat liquid cancers, solid tumors, and other serious diseases. Our proprietary, high-throughput platform identifies previously uncharacterized, clinically-derived shared T cell antigens and all off-target TCR interactions, to enable the development of highly efficacious TCR-Ts with minimal off-target effects. Lead program TSC-100 is expected to enter clinical development for liquid cancers in 2021, and the Company is advancing additional TCR-Ts for solid cancers.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    TScan TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    830 Winter St. Waltham, Ma 02451
    Telephone
    Telephone
    857-399-9500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.tscan.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/tscan-therapeutics
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    TScan Therapeutics to Present at 25th Annual Needham Healthcare
    TScan Therapeutics to Present at 25th Annual Needham Healthcare

    08 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/08/3269963/0/en/TScan-Therapeutics-to-Participate-in-the-25th-Annual-Needham-Virtual-Healthcare-Conference.html

    GLOBENEWSWIRE
    08 Apr 2026
    Share Share
    TScan Therapeutics Reports Q4/FY 2025 Results and Business Update
    TScan Therapeutics Reports Q4/FY 2025 Results and Business Update

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249222/0/en/TScan-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2025-Financial-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    TScan Therapeutics Completes Phase 1 ALLOHA Cohort C Enrollment
    TScan Therapeutics Completes Phase 1 ALLOHA Cohort C Enrollment

    26 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/26/3245412/0/en/TScan-Therapeutics-Completes-Enrollment-in-Cohort-C-of-Phase-1-ALLOHA-Trial-and-Announces-FDA-Clearance-of-Investigational-New-Drug-Applications-for-Heme-Candidates-TSC-102-A01-and.html

    GLOBENEWSWIRE
    26 Feb 2026
    Share Share
    TScan Therapeutics to Join TD Cowen 46th Annual Health Care
    TScan Therapeutics to Join TD Cowen 46th Annual Health Care

    25 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/25/3244454/0/en/TScan-Therapeutics-to-Participate-in-the-TD-Cowen-46th-Annual-Health-Care-Conference.html

    GLOBENEWSWIRE
    25 Feb 2026
    Share Share
    Tscan Therapeutics Reveals Positive ALLOHA Phase 1 Heme Trial
    Tscan Therapeutics Reveals Positive ALLOHA Phase 1 Heme Trial

    06 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/06/3201100/0/en/TScan-Therapeutics-Announces-Positive-Updated-Data-from-the-ALLOHA-Phase-1-Heme-Trial-at-the-67th-American-Society-of-Hematology-Annual-Meeting-and-Exposition.html

    GLOBENEWSWIRE
    06 Dec 2025
    Share Share
    Tscan Therapeutics Hosts Virtual KOL Event On ALLOHA Phase 1
    Tscan Therapeutics Hosts Virtual KOL Event On ALLOHA Phase 1

    03 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/03/3199335/0/en/TScan-Therapeutics-to-Host-Virtual-KOL-Event-to-Discuss-Clinical-Updates-from-the-ALLOHA-Phase-1-Trial-and-Future-Market-Opportunities.html

    GLOBENEWSWIRE
    03 Dec 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search